Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harp

Showing results (651-660 of 688) with videos related to

Pageof 69
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 28, 2021
Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M<sub>4</sub> muscarinic acetylcholine receptorAaron M Bender, Trever R Carter, Matthew Spock, et al.
European Journal of Immunology|September 3, 2010
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoproteinChristopher T Harp, Sara Ireland, Laurie S Davis, et al.
Advances in Radiation Oncology|February 14, 2020
Radiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal CarcinomaMona Kamal, Christopher Ryan Peeler, Pablo Yepes, et al.
The Lancet. Neurology|July 19, 2025
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension studyAmit Bar-Or, Michal Dufek, Hrvoje Budincevic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsDiana K Valencia, Wayne Silverman, Sigan L Hartley, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Discovery of VU6005649, a CNS Penetrant mGlu<sub>7/8</sub> Receptor PAM Derived from a Series of Pyrazolo[1,5-<i>a</i>]pyrimidinesMasahito Abe, Mabel Seto, Rocco G Gogliotti, et al.
Journal of the American Chemical Society|September 23, 2017
4'-C-Methoxy-2'-deoxy-2'-fluoro Modified Ribonucleotides Improve Metabolic Stability and Elicit Efficient RNAi-Mediated Gene SilencingElise Malek-Adamian, Dale C Guenther, Shigeo Matsuda, et al.
JAMA|March 19, 1997
A coccidioidomycosis outbreak following the Northridge, Calif, earthquakeE Schneider, R A Hajjeh, R A Spiegel, et al.
Ecology|April 11, 2025
Long-haul flights and migratory routes of a nectar-feeding batTheresa M Laverty, Debbie C Buecher, David C Dalton, et al.
ACS Chemical Neuroscience|April 28, 2018
A Novel M<sub>1</sub> PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic ToxicityJerri M Rook, Jeanette L Bertron, Hyekyung P Cho, et al.
Pageof 69

Showing results (651-660 of 688) with videos related to

Sort By:
Pageof 69
Bioorganic & Medicinal Chemistry Letters|November 28, 2021
Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M<sub>4</sub> muscarinic acetylcholine receptorAaron M Bender, Trever R Carter, Matthew Spock, et al.
European Journal of Immunology|September 3, 2010
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoproteinChristopher T Harp, Sara Ireland, Laurie S Davis, et al.
Advances in Radiation Oncology|February 14, 2020
Radiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal CarcinomaMona Kamal, Christopher Ryan Peeler, Pablo Yepes, et al.
The Lancet. Neurology|July 19, 2025
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension studyAmit Bar-Or, Michal Dufek, Hrvoje Budincevic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsDiana K Valencia, Wayne Silverman, Sigan L Hartley, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Discovery of VU6005649, a CNS Penetrant mGlu<sub>7/8</sub> Receptor PAM Derived from a Series of Pyrazolo[1,5-<i>a</i>]pyrimidinesMasahito Abe, Mabel Seto, Rocco G Gogliotti, et al.
Journal of the American Chemical Society|September 23, 2017
4'-C-Methoxy-2'-deoxy-2'-fluoro Modified Ribonucleotides Improve Metabolic Stability and Elicit Efficient RNAi-Mediated Gene SilencingElise Malek-Adamian, Dale C Guenther, Shigeo Matsuda, et al.
JAMA|March 19, 1997
A coccidioidomycosis outbreak following the Northridge, Calif, earthquakeE Schneider, R A Hajjeh, R A Spiegel, et al.
Ecology|April 11, 2025
Long-haul flights and migratory routes of a nectar-feeding batTheresa M Laverty, Debbie C Buecher, David C Dalton, et al.
ACS Chemical Neuroscience|April 28, 2018
A Novel M<sub>1</sub> PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic ToxicityJerri M Rook, Jeanette L Bertron, Hyekyung P Cho, et al.
Pageof 69